Since the emergence of the COVID-19 pandemic at the end of 2019, a massive vaccination
campaign has been undertaken rapidly and worldwide. Like other vaccines, the COVID-19 …

Vaccine-induced immune thrombotic thrombocytopenia (VITT), also known as thrombosis
with thrombocytopenia syndrome, is a catastrophic and life-threatening reaction to …

Vaccine-induced immune thrombotic thrombocytopenia (VITT) is a rare thromboembolic
complication of adenoviral-vectored SARS-CoV2 vaccines, mediated by antibodies directed …

Rare cases of COVID‐19 vaccinated individuals develop anti‐platelet factor 4 (PF4)
antibodies that cause thrombocytopenia and thrombotic complications, a syndrome referred …

Antibodies against platelet factor 4 (PF4), a protein released from alpha-granules of
activated platelets, may cause a number of pathophysiological conditions. The most …

In late February 2021, a prothrombotic syndrome was encountered for the first time in some
of the recipients of ChAdOx1 CoV‐19 vaccine (AstraZeneca, University of Oxford, and …

In order to improve the safety of COVID-19 vaccines, there is an urgent need to unravel the
pathogenesis of vaccine-induced immune thrombotic thrombocytopenia (VITT), a severe …

In the new science emanating from the COVID-19 pandemic, effective vaccine development
has made a huge difference and saved countless lives. Vaccine roll-out led to the …

Thrombosis with Thrombocytopenia Syndrome (TTS) or Vaccine-induced Immune
Thrombotic Thrombocytopenia (VITT) had been reported in patients receiving the Ad26 …

La Pandemia de COVID-19 que generó un estado de alarma por su gravedad clínica y su
rápida contagiosidad, hoy en día nos presenta otros problemas como las complicaciones …